General Information of Drug (ID: DM17G39)

Drug Name
ISIS 23452 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DM17G39

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SM-337 DMOSTP9 Discovery agent N.A. Investigative [2]
SM-131 DMP8VO6 Discovery agent N.A. Investigative [3]
SM-122 DMC7YQE Discovery agent N.A. Investigative [2]
ISIS 23454 DM7FPZV Discovery agent N.A. Investigative [1]
ISIS 23459 DM4PGRU Discovery agent N.A. Investigative [1]
ISIS 23414 DMOC0DT Discovery agent N.A. Investigative [1]
ISIS 23416 DMHQD76 Discovery agent N.A. Investigative [1]
ISIS 23412 DMJ0LB1 Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Apoptosis-2 messenger RNA (BIRC3 mRNA) TTAIWZN BIRC3_HUMAN Not Available [1]

References

1 US patent application no. 5,958,771, Antisense modulation of cellular inhibitor of Apoptosis-2 expression.
2 Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. J Med Chem. 2010 Sep 9;53(17):6361-7.
3 Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of ca... J Med Chem. 2008 Dec 11;51(23):7352-5.